Influence of taurine on phenotype expression of muscular dystrophy in Drosophila melanogaster

  • T. K. Orlov
  • S. M. Gorbulinska
  • H. M. Klepach
  • М. А. Kryzhanovska
  • N. Ia. Holub


Aim. To investigate the effect of 0.1% taurine on the manifestation of muscular dystrophy in Drosophila melanogaster mutants under both larval and adult feeding. Methods. Larval and adult feeding of 0.1 % taurine, construction of survival curves and study of moving activity, making thorax muscles histological preparations. Results. It has been shown the increasing of life span indexes (on 46-75%). moving activity (on 50-75%), decreasing of fatigue rates, and reducing of muscle damages (on 6-20%) in Drosophila dystrophy mutants under the influence of 0.1% taurine. Conclusions. The results indicate a positive effect of 0.1% taurine as a stimulant, antioxidant, myoprotector, blocker of fatigue processes in dystrophin mutants. However, following further studies on vertebrates, taurine may be recommended as a therapeutic agent in the treatment of Duchenne muscular dystrophy.

Keywords: Drosophila, dystrophin, miodystrophy, taurine.


Kamdar F., Garry D.J. Dystrophin-Deficient Cardiomyopathy. Journal of the American College of Cardiology. 2016. Vol. 67. P. 2533-2546. doi: 10.1016/j.jacc.2016.02.081

Nigro V., Piluso G. Spectrum of muscular dystrophies associated with sarcolemmal-protein genetic defects. Biochim Biophys Acta. 2015. Vol. 1852, No. 4. P. 585-593. doi: 10.1016/j.bbadis.2014.07.023

Boca S., Nishida M., Harris M., Rao S., Cheema A. et al. Discovery of metabolic biomarkers for Duchenne muscular dystrophy: within a natural history study. PLoS One. 2016. Vol. 11, No. 7. E159895. doi: 10.1371/journal.pone.0153461

Rishko V., Holub N., Chernyk Ya. Phenotypes of Drosophila melanogaster caused by dysfunction of dystrophin and dystroglycan. Biopolym. Cell. 2011. Vol. 27, No. 6. P. 423-431. doi: 10.7124/bc.000112

Kucherenko M., Yatsenko A., Ruohola-Baker H., Maksymiv D., Chernyk Ya. Drosophila melanogaster as a model system for searching of dystrophin-dystroglycan complex modifiers. Visnyk of Lviv. Univ. Biology series. 2008. No. 46. P. 71-77.

Guiraud S., Chen H., Burns D., Kay E., Davies K. Advances in genetic therapeutic strategies for Duchenne muscular dystrophy. Exp Physiol. 2015. Vol. 100, Is. 12. P. 1458-1467. doi: 10.1113/EP085308

Matthews E., Brassington R., Kuntzer T., Jichi F., Manzur A. Corticosteroids for the treatment of Duchenne muscular dystrophy. Cochrane Database Syst Rev. 2016. Vol. 5. CD003725. doi: 10.1002/14651858.CD003725.pub4

Robinson-Hamm J.N, Gersbach C.A. Gene therapies that restore dystrophin expression for the treatment of Duchenne muscular dystrophy. Hum Genet. 2016. Vol. 135, Is. 9. P. 1029-1040. doi: 10.1007/s00439-016-1725-z

Arthur P., Grounds M., Shavlakadze T. Oxidative stress as a therapeutic target during muscle wasting: considering the complex interactions. Curr Opin Clin Nutr Metab Care. 2008. Vol. 11. P. 408-416. doi: 10.1097/MCO.0b013e328302f3fe

Terrill J.R., Boyatzis A., Grounds M.D., Arthur P.G. Treatment with the cysteine precursor l-2-oxothiazolidine-4-carboxylate (OTC) implicates taurine deficiency in severity of dystropathology in mdx mice. Int J Biochem Cell Biol. 2013. Vol. 45, No. 9. P. 2097-2108. doi: 10.1016/j.biocel.2013.07.009

Terrill J., Radley-Crabb H., Grounds M., Arthur P. N-Acetylcysteine treatment of dystrophic mdx mice results in protein thiol modifications and inhibition of exercise induced myofibre necrosis. Neuromuscul Disord. 2012. Vol. 22, Is. 5. P. 427-434. doi: 10.1016/j.nmd.2011.11.007

Terrill J., Pinniger G., Graves J., Grounds M., Arthur P. Increasing taurine intake and taurine synthesis improves skeletal muscle function in the mdx mouse model for Duchenne muscular dystrophy. J Physiol. 2016. Vol. 594, Is. 11. P. 3095-3110. doi: 10.1113/JP271418

Terrill J., Grounds M., Arthur P. Taurine deficiency, synthesis and transport in the mdx mouse model for Duchenne Muscular Dystrophy. Int J Biochem Cell Biol. 2015. Vol. 66. P. 141-148. doi: 10.1016/j.biocel.2015.07.016

Shkryl V., Martins A., Ullrich N., Nowycky M., Niggli E., Shirokova N. Reciprocal amplification of ROS and Ca(2+) signals in stressed mdx dystrophic skeletal muscle fibers. Pflugers Arch. 2009. Vol. 458, No. 5. P. 915-928. doi: 10.1007/s00424-009-0670-2

Lin F., Pierce M., Sehgal A., Wu T., Skipper C., Chabba R. Effect of taurine and caffeine on sleep-wake activity in Drosophila melanogaster. Nat Sci Sleep. 2010. Vol. 2. P. 221-231. doi: 10.2147/NSS.S13034

Zemtsova Z., Stankevich L. Rol thiolovyh soedinienij v podderzhanii okislitelnogo homeostasa v protsesse sportivnoj podgotovki. Science in Olympic Sport. 2015. Vol. 2. P. 37-44 [in Russian]